Examkin

All practice questions

1849 questions

All types8,270Multiple choice4,249Multiple select325Numeric160Matching1,849Ordering1,687
Question 541Question →

Idiopathic inflammatory myopathies are characterized by distinct myositis-specific autoantibodies that strongly predict clinical phenotypes, organ involvement, and prognosis. Match each myositis-specific autoantibody with its most characteristic clinical phenotype or primary disease association.

Click a left item, then click its matching right item

Items

Anti-Jo-1 (anti-histidyl-tRNA synthetase)
Anti-SRP (signal recognition particle)
Anti-Mi-2 (nucleosome remodeling deacetylase complex)
Anti-MDA5 (melanoma differentiation-associated gene 5)
Anti-TIF1-gamma (transcriptional intermediary factor 1-gamma)

Matches

Show answer & explanation

Answer

Anti-Jo-1 matches with antisynthetase syndrome (mechanic's hands, ILD); Anti-SRP matches with severe necrotizing myopathy; Anti-Mi-2 matches with classic, steroid-responsive dermatomyositis; Anti-MDA5 matches with amyopathic dermatomyositis and rapidly progressive ILD; Anti-TIF1-gamma matches with malignancy-associated dermatomyositis.
Idiopathic inflammatory myopathies (IIMs) are heterogeneous. Myositis-specific antibodies (MSAs) allow for the categorization of IIMs into distinct clinical subsets. Recognizing these associations is critical for anticipating complications such as rapidly progressive interstitial lung disease (Anti-MDA5), occult malignancy (Anti-TIF1-gamma), or necrotizing autoimmune myopathy with cardiac involvement (Anti-SRP).

Step-by-Step Solution

1
Analyze the autoantibody profile in the context of idiopathic inflammatory myopathies.
Identify that the question tests high-yield, specific antibody-phenotype correlations beyond standard ANA testing.
Myositis-specific antibodies dictate the need for targeted screening (e.g., ILD, malignancy, cardiac involvement).
2
Differentiate the lung-predominant phenotypes.
Anti-Jo-1 is linked to standard antisynthetase syndrome, whereas Anti-MDA5 is linked to clinically amyopathic disease with rapidly progressive, often fatal interstitial lung disease and distinctive skin ulcerations.
Confusing these two can lead to underestimating the acuity of Anti-MDA5 lung disease.
3
Differentiate the skin and muscle-predominant phenotypes.
Anti-SRP lacks prominent skin findings and causes severe necrotizing myopathy. Anti-Mi-2 causes classic severe skin findings (heliotrope, Gottron) but has a good prognosis. Anti-TIF1-gamma causes severe skin findings but is highly paraneoplastic.
Each antibody defines a specific prognostic trajectory and screening requirement.

Key Concept

Myositis-specific autoantibodies and their corresponding clinical phenotypes
Question 542Question →

A pediatric clinic is reviewing the immunization records of several patients with specific underlying conditions or clinical circumstances. Match each pediatric patient with the specific vaccine or immunoprophylaxis that is most appropriately indicated for their ongoing care.

Click a left item, then click its matching right item

Items

A 16-year-old adolescent boy with a newly diagnosed terminal complement pathway deficiency
A 15-year-old adolescent girl who is currently at 28 weeks of gestation
A 3-year-old boy scheduled to undergo cochlear implant surgery next month
A 6-month-old infant boy born at 26 weeks gestation with bronchopulmonary dysplasia, presenting for a visit in late October

Matches

Show answer & explanation

Answer

The correct matches align specific high-risk pediatric conditions with their targeted immunizations: complement deficiency pairs with MenB, pregnancy pairs with Tdap, cochlear implants pair with PPSV23, and premature infants with lung disease pair with RSV immunoprophylaxis.
Each patient in the stem presents with a specific risk factor that directly alters their routine immunization requirements. Terminal complement deficiency requires MenB to prevent lethal meningococcal disease. Pregnancy necessitates Tdap in the third trimester for neonatal pertussis protection. Cochlear implants place children at high risk for pneumococcal meningitis, requiring PPSV23 in addition to standard conjugate vaccines. Premature infants with chronic lung disease require RSV immunoprophylaxis entering their first RSV season.

Step-by-Step Solution

1
Evaluate the immunization needs of the 16-year-old with terminal complement deficiency.
Matches with Meningococcal B (MenB) vaccine.
Terminal complement deficiency impairs the body's ability to lyse encapsulated bacteria, specifically creating a severe vulnerability to Neisseria meningitidis, necessitating complete meningococcal vaccination (MenACWY and MenB).
2
Evaluate the immunization needs of the pregnant 15-year-old at 28 weeks gestation.
Matches with Tdap vaccine.
Standard prenatal care guidelines require Tdap administration between 27-36 weeks in every pregnancy to ensure protective maternal antibodies are transferred to the infant against pertussis.
3
Evaluate the immunization needs of the 3-year-old needing a cochlear implant.
Matches with 23-valent pneumococcal polysaccharide vaccine (PPSV23).
Cochlear implants provide a potential anatomical pathway for bacteria to enter the central nervous system, heightening the risk for pneumococcal meningitis. PPSV23 expands serotype coverage for high-risk children over age 2.
4
Evaluate the immunization needs of the premature 6-month-old with bronchopulmonary dysplasia entering autumn.
Matches with RSV immunoprophylaxis.
Premature infants with chronic lung disease lack adequate airway reserves and maternal antibody transfer, requiring passive immunization against RSV during the peak transmission season.

Key Concept

Special immunization indications for pediatric patients with high-risk underlying conditions
Question 543Question →

Match each clinical presentation of an opportunistic infection in a patient with advanced HIV to its most appropriate first-line targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A patient with a CD4 count of 180 cells/mm³ presents with a 3-week history of progressively worsening dyspnea, dry cough, and bilateral interstitial infiltrates on chest radiograph.
A patient with a CD4 count of 80 cells/mm³ presents with a progressive headache, fever, and elevated opening pressure on lumbar puncture; cerebrospinal fluid India ink stain is positive for encapsulated yeast.
A patient with a CD4 count of 40 cells/mm³ presents with unilateral floaters, flashes of light, and decreased visual acuity; fundoscopy reveals yellow-white retinal exudates with perivascular hemorrhage.
A patient with a CD4 count of 70 cells/mm³ presents with a new-onset generalized seizure and focal weakness; brain MRI demonstrates multiple ring-enhancing lesions in the basal ganglia.

Matches

Show answer & explanation

Answer

Pneumocystis pneumonia is treated with trimethoprim-sulfamethoxazole; Cryptococcal meningitis with amphotericin B and flucytosine; CMV retinitis with valganciclovir; and Toxoplasma encephalitis with sulfadiazine, pyrimethamine, and leucovorin.
Each opportunistic infection has a distinct clinical presentation linked to specific CD4 count thresholds and requires a corresponding optimal, evidence-based antimicrobial regimen.

Step-by-Step Solution

1
Identify the underlying opportunistic pathogen for each clinical vignette based on the patient's CD4 count and specific presenting symptoms or diagnostic findings.
The vignettes correspond to Pneumocystis jirovecii pneumonia, Cryptococcal meningitis, cytomegalovirus retinitis, and Toxoplasma encephalitis, respectively.
Accurate pathogen identification is a prerequisite for selecting the appropriate targeted antimicrobial therapy.
2
Determine the first-line treatment regimen for each identified opportunistic infection.
PCP requires trimethoprim-sulfamethoxazole. Cryptococcus requires amphotericin B and flucytosine. CMV requires valganciclovir. Toxoplasmosis requires sulfadiazine, pyrimethamine, and leucovorin.
Targeted therapy ensures maximal efficacy while reducing mortality and inappropriate use of broad-spectrum antimicrobials.

Key Concept

First-line treatment of opportunistic infections in HIV patients based on clinical presentation and CD4 count.
Question 544Question →

Match each highly specific clinical scenario of an infectious disease with the most appropriate targeted pharmacologic management or intervention step, considering the patient's unique contraindications and risk factors.

Click a left item, then click its matching right item

Items

A 45-year-old hematopoietic stem cell transplant recipient with profound neutropenia develops a dense pulmonary consolidation with a surrounding ground-glass halo. Baseline electrocardiogram shows a QTc interval of 560 ms.
A 28-year-old female at 14 weeks gestation has a painless genital ulcer positive for spirochetes on dark-field microscopy. She has a documented history of severe amoxicillin-induced anaphylaxis.
A 65-year-old renal transplant recipient with a history of severe piperacillin-tazobactam anaphylaxis develops meningoencephalitis. Cerebrospinal fluid analysis reveals Gram-positive rods with tumbling motility.
A 55-year-old intensive care unit patient with severe acute kidney injury (creatinine 4.1 mg/dL) develops ventilator-associated pneumonia. Sputum culture grows Acinetobacter baumannii resistant to all carbapenems and aminoglycosides.
A 20-year-old female seeks meningococcal post-exposure prophylaxis after close contact with an infected roommate. She takes combined oral contraceptives and has a known history of congenital long QT syndrome.

Matches

Show answer & explanation

Answer

Each clinical scenario requires matching the pathogen or exposure with a highly specific antimicrobial agent that safely navigates the patient's major contraindication (e.g., QTc prolongation, teratogenicity, nephrotoxicity, or drug-drug interactions).
The correct pairings require a synthesis of microbiology and pharmacology. The Aspergillus patient requires isavuconazole to avoid life-threatening arrhythmias. The pregnant syphilis patient requires penicillin desensitization as no safe alternatives exist. The Listeria patient requires trimethoprim-sulfamethoxazole to bypass penicillin anaphylaxis while maintaining efficacy. The CRAB patient requires cefiderocol to avoid polymyxin-induced renal failure. The meningococcal prophylaxis patient requires ceftriaxone to avoid contraceptive failure from rifampin and fatal arrhythmias from ciprofloxacin.

Step-by-Step Solution

1
Analyze the immunocompromised patient with the pulmonary halo sign and QTc of 560 ms.
Identify invasive aspergillosis. Recognize that voriconazole is contraindicated due to severe QTc prolongation. Select isavuconazonium sulfate.
Isavuconazole is a broad-spectrum triazole that uniquely shortens rather than prolongs the QTc interval.
2
Evaluate the pregnant patient with primary syphilis and penicillin anaphylaxis.
Identify that penicillin is absolutely required in pregnancy to prevent congenital syphilis. Select penicillin desensitization followed by benzathine penicillin G.
Alternative therapies are strictly contraindicated due to fetal harm or high resistance rates, necessitating the desensitization process despite the allergy.
3
Assess the post-transplant patient with Listeria meningitis and penicillin anaphylaxis.
Identify Listeria (Gram-positive rods with tumbling motility) and note the ampicillin allergy. Select trimethoprim-sulfamethoxazole.
Cephalosporins (including ceftriaxone and cefiderocol) do not cover Listeria. Trimethoprim-sulfamethoxazole is the drug of choice for Listeria in penicillin-allergic patients.
4
Review the ICU patient with carbapenem-resistant Acinetobacter baumannii (CRAB) and severe acute kidney injury.
Acknowledge the need for CRAB coverage while avoiding extreme nephrotoxins like polymyxins. Select cefiderocol.
Cefiderocol provides targeted therapy against CRAB via a novel siderophore mechanism, sparing the patient from the renal failure exacerbation seen with colistin.
5
Analyze the patient requiring meningococcal prophylaxis who takes oral contraceptives and has long QT syndrome.
Rule out rifampin (CYP450 induction ruins oral contraceptive efficacy) and ciprofloxacin (prolongs QTc). Select intramuscular ceftriaxone.
Ceftriaxone safely avoids both the drug-drug interaction and the cardiac electrophysiologic risk.

Key Concept

Advanced antimicrobial stewardship requires integrating microbiologic efficacy with patient-specific pharmacologic contraindications, including QTc interval prolongation, renal function, pregnancy status, and drug interactions.
Estimated Time:2m 30s
Question 545Question →

A hematology consultation service is reviewing the clinical data and coagulation profiles of five distinct adult patients. Based on the patterns of standard coagulation testing (PT, aPTT), mixing studies, and clinical presentation, match each patient's profile to the most accurate underlying diagnosis.

Click a left item, then click its matching right item

Items

Normal PT, normal aPTT, normal platelet count; abnormal clot solubility in 5M urea; presentation of severe delayed wound hemorrhage after minor surgery.
Prolonged PT, normal aPTT; corrects immediately with normal plasma mix; normal platelet count; patient has severe malnutrition and has been on prolonged broad-spectrum antibiotics.
Prolonged aPTT, normal PT; 1:1 mixing study shows initial correction, but the aPTT prolongs again after 2 hours of incubation at 37°C; patient presents with massive spontaneous gluteal hematoma.
Prolonged aPTT, normal PT; 1:1 mixing study fails to correct immediately; normal bleeding time; patient has a history of recurrent deep vein thromboses and mid-trimester pregnancy losses.
Prolonged PT and aPTT; isolated severe reduction in Factor X activity; patient presents with periorbital purpura, macroglossia, and nephrotic-range proteinuria.

Matches

Show answer & explanation

Answer

Profile 1 matches Factor XIII deficiency; Profile 2 matches Early vitamin K deficiency; Profile 3 matches Acquired hemophilia A; Profile 4 matches Antiphospholipid syndrome; Profile 5 matches Systemic AL amyloidosis.
The correct pairings require synthesis of clinical signs and advanced hematologic testing. Factor XIII deficiency selectively fails the 5M urea clot solubility test because fibrin is not cross-linked, causing delayed bleeding. Early vitamin K deficiency rapidly depletes Factor VII (shortest half-life), prolonging the PT, which corrects on a standard mixing study. Acquired hemophilia A (Factor VIII inhibitor) is classically time- and temperature-dependent, showing initial correction followed by prolongation. Lupus anticoagulant immediately binds phospholipids, causing immediate non-correction of the aPTT without bleeding, instead driving thrombosis. Systemic AL amyloidosis uniquely causes isolated Factor X deficiency due to direct fibril binding, presenting alongside macroglossia and nephropathy.

Step-by-Step Solution

1
Analyze standard coagulation tests (PT and aPTT) to determine the affected pathways.
Isolated PT prolongation points to the extrinsic pathway; isolated aPTT points to the intrinsic pathway; combined points to the common pathway; entirely normal tests with delayed bleeding suggest structural fibrin cross-linking issues.
Basic coagulation cascade interpretation sets the foundation for diagnosing hemostatic disorders.
2
Evaluate mixing study results for the profiles with prolonged tests.
Immediate correction suggests a simple factor deficiency (e.g., Vitamin K deficiency). Immediate non-correction suggests an immediate inhibitor (Lupus anticoagulant). Time-dependent non-correction suggests a slow-acting inhibitor (Factor VIII autoantibody).
Mixing studies differentiate between missing factors and the presence of acquired neutralizing antibodies or phospholipid inhibitors.
3
Incorporate specific clinical syndromes and unique laboratory phenomena.
The 5M urea test specifically identifies Factor XIII. The triad of macroglossia, periorbital purpura, and nephropathy points to AL amyloidosis, which exhibits unique Factor X binding. Broad-spectrum antibiotics and malnutrition point to Vitamin K depletion.
Advanced diagnosis requires integrating abstract laboratory phenomena with systemic physical exam findings.

Key Concept

Advanced integration of coagulation cascade abnormalities, mixing studies, and systemic disease associations.
Question 546Question →

Evaluate the following four patient presentations encountered in the acute internal medicine setting. Match each clinical vignette describing a toxicological emergency with the most appropriate definitive pharmacologic intervention.

Click a left item, then click its matching right item

Items

A 31-year-old patient undergoes an endoscopy using topical anesthetics. Post-procedure, pulse oximetry reads 85%85\% despite high-flow oxygen, while arterial blood gas reveals a normal PaO2PaO_2. Blood drawn for testing appears dark and viscous.
A 46-year-old patient is found obtunded. Laboratory evaluation reveals a pH=7.15pH = 7.15, a serum bicarbonate of 10 mEq/L10 \text{ mEq/L}, an elevated osmolar gap, and a normal serum lactate level. Urine microscopy demonstrates calcium oxalate crystalluria.
A 58-year-old patient with ischemic heart disease presents with profound hypotension and bradycardia. The patient remains refractory to intravenous fluids, atropine, and vasopressor therapy. Bedside echocardiogram shows globally depressed myocardial contractility.
A 65-year-old patient with hypertensive emergency is treated with a potent intravenous vasodilator infusion. Forty-eight hours later, the patient develops confusion, severe unexplained lactic acidosis, and an abnormally elevated mixed venous oxygen saturation.

Matches

Show answer & explanation

Answer

The correct pairings are: the post-endoscopy hypoxia patient with intravenous methylene blue; the obtunded patient with crystalluria with intravenous fomepizole; the refractory bradycardic patient with intravenous glucagon; and the nitroprusside toxicity patient with intravenous hydroxocobalamin.
Each specific toxicological emergency relies on identifying unique clinical markers: a saturation gap for methemoglobinemia (treated with methylene blue); osmolar gap with crystalluria for ethylene glycol (treated with fomepizole); refractory bradycardic shock for beta-blocker overdose (treated with glucagon); and lactic acidosis with high mixed venous oxygen post-nitroprusside for cyanide toxicity (treated with hydroxocobalamin).

Step-by-Step Solution

1
Analyze the first clinical vignette for specific physiological discrepancies.
Identify a saturation gap (low pulse oximetry, normal arterial PaO2PaO_2) and dark blood following topical anesthetic use, diagnostic of methemoglobinemia.
Topical anesthetics are classic oxidizing agents. Methylene blue is the specific antidote to reduce oxidized iron in hemoglobin.
2
Analyze the laboratory findings in the second clinical vignette.
Identify an elevated osmolar gap, severe metabolic acidosis, and calcium oxalate crystals without elevated lactate, indicative of ethylene glycol ingestion.
Ethylene glycol requires immediate blockade of alcohol dehydrogenase with fomepizole to prevent renal failure and severe systemic toxicity.
3
Evaluate the third clinical vignette's hemodynamic profile.
Identify refractory cardiogenic shock (bradycardia and hypotension) unresponsive to standard vasopressors and atropine, classic for severe beta-blocker toxicity.
Definitive management requires an alternative pathway to increase intracellular cAMPcAMP, which is achieved by administering intravenous glucagon.
4
Assess the iatrogenic complication in the fourth clinical vignette.
Identify cyanide toxicity secondary to prolonged sodium nitroprusside infusion, evidenced by lactic acidosis and impaired cellular oxygen extraction (high mixed venous oxygen).
Cyanide binds mitochondrial cytochrome oxidase. Hydroxocobalamin acts as a direct cyanide scavenger, forming non-toxic cyanocobalamin.

Key Concept

Diagnosis of acute toxicological emergencies based on pathognomonic clinical and laboratory findings, and the subsequent selection of definitive targeted antidotes.
Question 547Question →

Match each patient's clinical presentation and laboratory profile with the most likely corresponding peripheral blood smear finding.

Click a left item, then click its matching right item

Items

A 24-year-old man develops acute jaundice and dark urine 2 days after initiating trimethoprim-sulfamethoxazole. Vitals: T 37.2°C, HR 105, BP 120/78. Exam shows scleral icterus. Labs: Hemoglobin 8.5 g/dL, Total bilirubin 4.2 mg/dL, Direct bilirubin 0.6 mg/dL.
A 45-year-old home renovator presents with colicky abdominal pain and wrist drop. Vitals: T 37.0°C, HR 88, BP 145/90. Exam shows right hand extensor weakness. Labs: Hemoglobin 9.2 g/dL, MCV 78 fL, Creatinine 1.4 mg/dL.
A 29-year-old woman with a history of recurrent vaso-occlusive crises presents for a checkup. Vitals: T 36.8°C, HR 82, BP 115/75. Exam shows no palpable spleen. Labs: Hemoglobin 7.8 g/dL, Reticulocytes 8.5%, WBC 12,000/mm³.
A 34-year-old woman with systemic lupus erythematosus presents with rapidly worsening fatigue. Vitals: T 37.5°C, HR 112, BP 110/70. Exam shows pale conjunctivae and jaundice. Labs: Hemoglobin 7.1 g/dL, Reticulocytes 11%, LDH 650 U/L, positive direct antiglobulin test.

Matches

Show answer & explanation

Answer

The sulfonamide-induced hemolysis matches Heinz bodies and bite cells; the home renovator with wrist drop matches basophilic stippling; the sickle cell patient matches Howell-Jolly bodies; and the lupus patient with a positive direct antiglobulin test matches spherocytes.
Each vignette represents a classic hematologic presentation where the peripheral blood smear serves as a critical diagnostic tool, reflecting the exact underlying mechanism of erythrocyte damage, abnormal maturation, or failed splenic clearance.

Step-by-Step Solution

1
Analyze each clinical vignette to establish the primary pathophysiologic diagnosis.
Diagnoses identified: 1 is G6PD deficiency, 2 is lead poisoning, 3 is sickle cell disease with autosplenectomy, and 4 is warm autoimmune hemolytic anemia.
Correctly identifying the underlying disease process is a prerequisite to anticipating its microscopic cellular features.
2
Correlate the identified diagnoses with classic peripheral blood smear morphological changes.
G6PD deficiency links to Heinz bodies/bite cells. Lead poisoning links to basophilic stippling. Autosplenectomy links to Howell-Jolly bodies. Warm AIHA links to spherocytes.
Specific pathophysiological mechanisms directly dictate the morphological alterations of erythrocytes visible on a peripheral smear.

Key Concept

Correlating clinical presentations of hematologic disorders with their characteristic pathophysiological peripheral blood smear findings.
Question 548Question →

Match each patient's clinical presentation with the most appropriate specific therapeutic intervention.

Click a left item, then click its matching right item

Items

A 42-year-old man on monotherapy for latent tuberculosis is brought in actively seizing. Seizures have persisted for 20 minutes despite adequate doses of intravenous midazolam and phenytoin. Laboratory testing reveals a profound unexplained metabolic acidosis.
A 68-year-old man with opioid use disorder maintained on a synthetic mu-opioid agonist is treated with a macrolide antibiotic for an upper respiratory infection. He presents with recurrent syncope. Telemetry shows bursts of wide-complex tachycardia with constantly changing amplitude around the isoelectric line.
A 55-year-old woman with recurrent depression, stably managed on a long-acting selective serotonin reuptake inhibitor, is hospitalized for a complex soft tissue infection and started on an oxazolidinone antibiotic. Within 48 hours, she develops severe agitation, diaphoresis, a temperature of 39.8°C (103.6°F), and spontaneous myoclonus.
A 34-year-old man managed for acute mania presents with profound confusion, a coarse intentional tremor, and new-onset ataxia after a recent bout of severe rotavirus diarrhea. His estimated glomerular filtration rate has acutely dropped to 25 mL/min/1.73m², and a specific serum drug assay returns at 4.6 mEq/L.
A 75-year-old woman with chronic systolic heart failure and atrial fibrillation presents with anorexia, vomiting, and fatigue. Her spouse notes she recently complained of a yellowish tint to her vision. Cardiac monitoring demonstrates bidirectional ventricular tachycardia, and serum potassium is 5.9 mEq/L.

Matches

Show answer & explanation

Answer

Latent TB/seizures matches Intravenous pyridoxine. Methadone/macrolide/polymorphic VT matches Intravenous magnesium sulfate. SSRI/linezolid/hyperthermia matches Oral cyproheptadine. Lithium tox/AKI matches Emergent hemodialysis. Heart failure/xanthopsia/bidirectional VT matches Digoxin-specific antibody fragments.
Each correct pairing links a complex toxicological presentation with its specific, life-saving intervention. Isoniazid depletes pyridoxine, leading to refractory seizures. Methadone and macrolides interact to cause QT prolongation and Torsades de pointes, treated with magnesium. Linezolid and SSRIs interact to cause serotonin syndrome, treated with cyproheptadine. Lithium toxicity > 4.0 mEq/L with AKI requires hemodialysis. Digoxin toxicity presenting with severe hyperkalemia and bidirectional VT requires specific antibody fragments.

Step-by-Step Solution

1
Analyze each patient's clinical presentation and medication history to identify the specific toxidrome or adverse drug reaction.
Patient 1 has isoniazid toxicity. Patient 2 has Torsades de pointes from QT-prolonging agents. Patient 3 has serotonin syndrome. Patient 4 has lithium toxicity. Patient 5 has digoxin toxicity.
Accurate recognition of life-threatening toxidromes based on nuanced historical clues is required before selecting an antidote.
2
Select the definitive, targeted therapy for each identified condition, bypassing generic algorithmic treatments that may be ineffective or harmful.
Pyridoxine for isoniazid seizures; magnesium for Torsades; cyproheptadine for serotonin syndrome; hemodialysis for severe lithium toxicity; and digoxin-specific antibodies for digoxin toxicity with hyperkalemia.
Toxicological emergencies often require specific antidotes or extracorporeal removal rather than standard supportive care.

Key Concept

Targeted management and antidote selection for complex, multi-drug or severe toxicological emergencies in internal medicine.
Question 549Question →

For each patient presentation describing a new diagnosis of primary hypertension with specific comorbidities, select the most appropriate preferred initial antihypertensive medication class.

Click a left item, then click its matching right item

Items

A 62-year-old female with a recent dual-energy x-ray absorptiometry scan indicating significant bone mineral density loss.
A 55-year-old male with chronic kidney disease and a urine albumin-to-creatinine ratio of 400 mg/g.
A 45-year-old female who reports frequent, painful episodes of digital pallor and cyanosis when exposed to cold environments.
A 50-year-old male with a history of an anterior wall myocardial infarction three months ago and a left ventricular ejection fraction of 40%.

Matches

Show answer & explanation

Answer

Osteoporosis is treated with a Thiazide diuretic; CKD with albuminuria is treated with an ACE inhibitor; Raynaud phenomenon is treated with a Dihydropyridine calcium channel blocker; and prior MI is treated with a Beta-adrenergic antagonist.
Each patient's presentation includes a specific comorbidity that dictates a preferred antihypertensive class based on secondary therapeutic benefits and established mortality reduction guidelines.

Step-by-Step Solution

1
Identify the primary compelling indication or comorbidity in each patient's presentation.
Patient 1 has osteoporosis. Patient 2 has CKD with overt albuminuria. Patient 3 has Raynaud phenomenon. Patient 4 has a prior myocardial infarction with reduced ejection fraction.
Current hypertension guidelines recommend tailoring initial medical therapy based on specific comorbid conditions to maximize therapeutic benefit.
2
Match each identified comorbidity to the antihypertensive class that provides the most advantageous secondary benefit or mortality reduction.
Osteoporosis benefits from thiazides due to calcium retention. CKD with albuminuria requires ACE inhibitors for renoprotection. Raynaud phenomenon improves with the vasodilatory effects of dihydropyridines. A prior MI requires beta-blockers to reduce cardiac workload and improve survival.
Selecting the optimal pharmacological agent requires synthesizing the diagnosis with the pleiotropic effects of the medication.

Key Concept

Tailoring initial antihypertensive therapy based on compelling clinical indications and patient-specific comorbidities.
Question 550Question →

Match the following key socioemotional and play milestones to the most typical chronological age at which they first emerge during normal pediatric development.

Click a left item, then click its matching right item

Items

2 months
6 months
9 months
24 months (2 years)
48 months (4 years)

Matches

Show answer & explanation

Answer

The correct matching correctly aligns normal socioemotional development: 2 months with the social smile, 6 months with stranger anxiety, 9 months with separation anxiety, 24 months with parallel play, and 48 months with cooperative play.
Each socioemotional milestone aligns with highly standardized pediatric developmental timelines. Two-month-olds begin to smile socially. Six-month-olds recognize their primary caregivers and exhibit fear of strangers. Nine-month-olds understand that caregivers still exist even when out of sight, causing separation anxiety. Two-year-olds play alongside peers independently (parallel play), and four-year-olds play together with shared goals (cooperative play).

Step-by-Step Solution

1
Identify the earliest social milestone, the social smile.
The social smile reliably appears at 2 months of age.
This is the first major reciprocal socioemotional milestone assessed in well-child visits.
2
Differentiate between the onset of stranger anxiety and separation anxiety.
Stranger anxiety typically emerges around 6 months, followed by separation anxiety at 9 months.
Stranger anxiety relies on recognizing familiar versus unfamiliar faces. Separation anxiety requires the subsequent development of object permanence.
3
Distinguish between types of play based on the child's age in years.
Parallel play matches 24 months (2 years), while cooperative play matches 48 months (4 years).
Toddlers lack the theory of mind required for shared goals (parallel play), whereas preschool-aged children develop the capacity to negotiate rules and share tasks (cooperative play).

Key Concept

Normal socioemotional and play development in pediatrics follows a predictable chronological sequence, progressing from basic interpersonal responses to complex peer interactions.
Question 551Question →

Match each patient's clinical presentation with the most appropriate initial pharmacological intervention.

Click a left item, then click its matching right item

Items

A 45-year-old man with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of 22% and an LDL cholesterol of 145 mg/dL
A 50-year-old woman with newly diagnosed type 2 diabetes mellitus, a hemoglobin A1c of 7.8%, and normal renal function
A 60-year-old man with newly diagnosed primary hypertension and osteoporosis, with no history of diabetes or heart failure
A 55-year-old woman with chronic kidney disease, severe albuminuria, and newly diagnosed primary hypertension

Matches

Show answer & explanation

Answer

The correct matches pair each specific clinical presentation with its guideline-directed first-line pharmacological therapy.
Each correct pairing reflects the standard of care for initial pharmacological management in primary care: statins for high ASCVD risk, biguanides for uncomplicated type 2 diabetes, thiazides for hypertension with osteoporosis, and ACE inhibitors for hypertension with proteinuric CKD.

Step-by-Step Solution

1
Analyze the lipid profile and ASCVD risk.
Identify the indication for a high-intensity statin.
Current guidelines recommend high-intensity statin therapy for primary prevention in patients with a 10-year ASCVD risk of 20% or higher.
2
Analyze the new diabetes diagnosis.
Identify the indication for metformin.
A biguanide is the established first-line agent for newly diagnosed type 2 diabetes mellitus.
3
Analyze the hypertension case with comorbid osteoporosis.
Identify the indication for a thiazide diuretic.
Thiazides promote renal calcium reabsorption, improving bone mineral density while effectively lowering blood pressure.
4
Analyze the hypertension case with comorbid CKD and albuminuria.
Identify the indication for an ACE inhibitor.
ACE inhibitors reduce intraglomerular pressure, specifically slowing the progression of proteinuric kidney disease.

Key Concept

First-line pharmacological management of common outpatient chronic diseases
Question 552Question →

For each of the following classic clinical presentations of infectious diseases, select the most appropriate first-line targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 20-year-old male notes a single, indurated, painless ulcer on his glans penis. He has bilateral rubbery inguinal lymph nodes. Point-of-care darkfield microscopy shows spirochetes.
A 22-year-old female college student complains of painful urination and increased urinary frequency for two days. She is afebrile and has no costovertebral angle tenderness.
A 54-year-old male develops a 10-cm annular rash with central clearing on his lower extremity two weeks after a camping trip in Connecticut.
A 32-year-old female presents with a profuse, malodorous, yellow-green vaginal discharge and vulvar irritation. Wet mount microscopy reveals motile, flagellated protozoa.

Matches

Show answer & explanation

Answer

Primary syphilis matches with intramuscular benzathine penicillin G. Uncomplicated acute cystitis matches with oral nitrofurantoin. Early localized Lyme disease matches with oral doxycycline. Trichomoniasis matches with oral metronidazole.
Each specific clinical scenario presents classic pathognomonic signs of an infectious disease that corresponds directly to a well-established, first-line antimicrobial therapy per current medical guidelines.

Step-by-Step Solution

1
Analyze the first clinical vignette to identify the underlying pathogen or disease state.
The painless chancre and spirochetes indicate primary syphilis.
Accurate diagnosis is required to select the correct targeted antimicrobial.
2
Identify the standard first-line therapy for the diagnosed condition.
Primary syphilis is treated with intramuscular benzathine penicillin G.
Treatment guidelines dictate specific regimens to ensure efficacy and prevent complications.
3
Repeat the diagnostic and therapeutic pairing process for the remaining vignettes.
Cystitis pairs with nitrofurantoin; Lyme disease pairs with doxycycline; Trichomoniasis pairs with metronidazole.
Each distinct presentation requires a specific targeted agent.

Key Concept

First-line empiric and targeted antimicrobial therapies for classic infectious disease presentations.
Estimated Time:1m 30s
Question 553Question →

Match each clinical presentation of infective endocarditis or severe bacteremia to its most appropriate targeted antimicrobial regimen.

Click a left item, then click its matching right item

Items

Prosthetic aortic valve (placed 3 months ago) endocarditis growing methicillin-resistant Staphylococcus epidermidis (MRSE)
Native mitral valve endocarditis growing Enterococcus faecalis in a patient with stage 3 chronic kidney disease
Native tricuspid valve endocarditis growing methicillin-susceptible Staphylococcus aureus (MSSA) currently on empiric vancomycin
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with a rapidly rising serum creatinine on day 4 of vancomycin therapy

Matches

Show answer & explanation

Answer

Prosthetic valve MRSE matches with Vancomycin/Rifampin/Gentamicin. E. faecalis with CKD matches with Ampicillin/Ceftriaxone. MSSA matches with Cefazolin. MRSA with nephrotoxicity matches with Daptomycin.
Each correct pairing aligns with infectious disease guidelines: staphylococcal prosthetic valves require rifampin and gentamicin adjuncts; MSSA strictly requires beta-lactam de-escalation; enterococcal endocarditis with renal impairment requires aminoglycoside-sparing dual beta-lactams; and vancomycin-induced nephrotoxicity necessitates a switch to daptomycin.

Step-by-Step Solution

1
Analyze the prosthetic valve endocarditis case (MRSE).
Identify the need for biofilm penetration.
Staphylococcal infections of prosthetic material develop robust biofilms. Rifampin is required to penetrate the biofilm, but it cannot be used alone due to rapid resistance. It must be combined with vancomycin (for MRSE) and gentamicin (for early synergy).
2
Analyze the E. faecalis endocarditis case with chronic kidney disease.
Select a synergistic regimen that spares the kidneys.
Enterococcal endocarditis requires synergy. While ampicillin plus gentamicin is traditional, ampicillin plus ceftriaxone achieves synergy through dual penicillin-binding protein inhibition and completely avoids nephrotoxic aminoglycosides.
3
Evaluate the MSSA endocarditis case on empiric vancomycin.
Determine the optimal definitive therapy.
Vancomycin is inferior to anti-staphylococcal penicillins (nafcillin) or first-generation cephalosporins (cefazolin) for MSSA. Standard antimicrobial stewardship dictates de-escalation to cefazolin.
4
Assess the MRSA bacteremia case complicated by acute kidney injury.
Choose a bactericidal agent active against MRSA with a different toxicity profile.
Vancomycin is notoriously nephrotoxic. Daptomycin is highly bactericidal against MRSA and is not nephrotoxic, making it the ideal switch when acute kidney injury occurs.

Key Concept

Targeted antimicrobial therapy for bacteremia and endocarditis requires adjustment based on pathogen susceptibility (e.g., MRSA vs. MSSA), infection site (prosthetic biofilm vs. native valve), and patient-specific toxicities (nephrotoxicity).
Question 554Question →

As part of an introductory hematopathology module, a medical trainee is asked to correlate microscopic cellular abnormalities with their corresponding disease states. Match each classic peripheral blood smear description with the diagnosis it most strongly suggests.

Click a left item, then click its matching right item

Items

Hypersegmented neutrophils
Auer rods
Smudge cells
Schistocytes

Matches

Show answer & explanation

Answer

Hypersegmented neutrophils match with Megaloblastic anemia; Auer rods match with Acute myeloid leukemia; Smudge cells match with Chronic lymphocytic leukemia; Schistocytes match with Microangiopathic hemolytic anemia.
Each classic morphological finding directly corresponds to the underlying pathophysiology of a specific hematologic disorder: impaired DNA synthesis yields hypersegmented neutrophils, abnormal myeloblast granulation produces Auer rods, clonal fragile B-cells manifest as smudge cells, and intravascular mechanical shearing creates schistocytes.

Step-by-Step Solution

1
Identify the cellular origin and pathophysiology of hypersegmented neutrophils.
Linked to impaired DNA synthesis affecting myeloid maturation, specifically pointing to Megaloblastic anemia.
Vitamin B12 and folate are required for normal DNA synthesis; deficiency leads to nuclear-cytoplasmic asynchrony.
2
Recognize the clinical significance of Auer rods.
Matched with Acute myeloid leukemia.
Auer rods confirm the myeloblastic lineage of the leukemic cells, ruling out lymphoblastic leukemias.
3
Recall the conditions associated with fragile white blood cells that rupture on smear preparation (smudge cells).
Matched with Chronic lymphocytic leukemia.
CLL is characterized by a monoclonal proliferation of incompetent, structurally fragile B lymphocytes.
4
Determine the mechanism behind red blood cell fragmentation (schistocytes).
Matched with Microangiopathic hemolytic anemia.
Intravascular shearing by microthrombi (as in TTP, HUS, or DIC) produces these distinct fragmented shapes.

Key Concept

Recognition of pathognomonic peripheral blood smear findings is a foundational diagnostic skill in hematology that directly guides subsequent clinical workup.
Estimated Time:45s
Question 555Question →

Match the following clinical scenarios of oncologic therapy and associated toxicities with the most appropriate pharmacological rescue or prophylactic agent.

Click a left item, then click its matching right item

Items

A 42-year-old woman with breast cancer receives a chemotherapy agent known to cause dose-dependent generation of free radicals, leading to cumulative, irreversible dilated cardiomyopathy.
A 35-year-old man with non-Hodgkin lymphoma receives an alkylating agent that is metabolized in the kidney to acrolein, placing him at high risk for severe hemorrhagic cystitis.
A 22-year-old man with acute lymphoblastic leukemia receives a high-dose antimetabolite that competitively inhibits dihydrofolate reductase, leading to severe myelosuppression.
A 15-year-old boy with Burkitt lymphoma is initiating induction chemotherapy for a massive tumor burden, placing him at high risk for acute kidney injury from profound hyperuricemia.

Matches

Show answer & explanation

Answer

The correct matches align each specific chemotherapy-induced toxicity mechanism with its targeted pharmacological rescue or prophylactic agent: Anthracycline cardiotoxicity requires Dexrazoxane; Acrolein-induced cystitis requires Mesna; Methotrexate myelosuppression requires Leucovorin; and hyperuricemia in Tumor Lysis Syndrome is treated with Rasburicase.
Each pair correctly matches a specific oncologic toxicity or complication with its mechanistically appropriate pharmacological intervention. Dexrazoxane chelates iron to prevent anthracycline cardiotoxicity. Mesna binds acrolein to prevent cyclophosphamide-induced cystitis. Leucovorin bypasses DHFR inhibition to rescue normal cells from methotrexate. Rasburicase degrades uric acid to prevent nephropathy in tumor lysis syndrome.

Step-by-Step Solution

1
Analyze the first scenario to identify the underlying chemotherapy agent and its toxic mechanism.
The agent described is an anthracycline (e.g., doxorubicin), which causes free-radical mediated dilated cardiomyopathy.
Recognizing the pathophysiology is required to select the correct cardioprotectant, which is Dexrazoxane.
2
Identify the cause and prevention of hemorrhagic cystitis in the second scenario.
The alkylating agent (cyclophosphamide) produces acrolein, which is neutralized by Mesna.
Mesna specifically concentrates in the bladder to bind acrolein, preventing urothelial toxicity.
3
Determine the rescue agent for the patient receiving the dihydrofolate reductase inhibitor in the third scenario.
The drug is methotrexate, and its toxicity is mitigated by Leucovorin (folinic acid).
Leucovorin provides the active form of folate, bypassing the blocked enzyme and rescuing rapidly dividing normal cells.
4
Select the most appropriate prophylactic agent for severe hyperuricemia in the fourth scenario.
The high tumor burden puts the patient at risk for tumor lysis syndrome, which is aggressively managed with Rasburicase.
Rasburicase enzymatically degrades uric acid to allantoin, rapidly preventing urate crystal nephropathy in high-risk patients.

Key Concept

Pharmacological prevention and rescue of specific chemotherapy-induced toxicities and oncologic emergencies.
Estimated Time:2m 0s
Question 556Question →

Match the following classic clinical descriptions of benign neonatal skin findings with their most likely diagnoses.

Click a left item, then click its matching right item

Items

Erythematous macules with central yellow-white papules on the trunk and extremities, showing prominent eosinophils on microscopic evaluation.
Firm, pearly-white papules on the nose and cheeks of a newborn, consisting of superficial epidermal keratin cysts.
Flat, blue-gray macular patches with poorly defined margins, typically found on the lumbosacral region of dark-skinned infants.
Vesiculopustular rash without surrounding erythema that quickly ruptures, leaving hyperpigmented macules and showing neutrophils on microscopy.

Matches

Show answer & explanation

Answer

The correct matches are: Erythematous macules with eosinophils match Erythema toxicum neonatorum. Pearly-white keratin cysts match Milia. Blue-gray sacral macules match Congenital dermal melanocytosis. Vesiculopustules without erythema showing neutrophils match Transient neonatal pustular melanosis.
Each clinical description maps uniquely to a classic, benign neonatal skin condition. Recognizing these patterns is essential to avoid unnecessary testing or treatments and to provide appropriate reassurance to parents.

Step-by-Step Solution

1
Analyze the microscopic contents and visual appearance of the vesicular/pustular rashes.
Eosinophils identify erythema toxicum neonatorum, while neutrophils identify transient neonatal pustular melanosis. Keratin identifies milia.
Differentiating these benign rashes often relies on the cellular contents of the lesions.
2
Evaluate the non-pustular, pigmented lesions based on color and location.
Blue-gray pigmentation on the sacrum perfectly describes congenital dermal melanocytosis.
Identifying characteristic pigmentation patterns prevents misdiagnosing benign lesions as child abuse (bruising).

Key Concept

Benign Neonatal Dermatological Findings
Question 557Question →

Match each autoantibody profile to the rheumatologic condition with which it is most specifically associated.

Click a left item, then click its matching right item

Items

Anti-Scl-70 (anti-topoisomerase I) antibodies
Anti-Jo-1 (anti-histidyl-tRNA synthetase) antibodies
Anti-U1 ribonucleoprotein (anti-U1 RNP) antibodies
Anti-cyclic citrullinated peptide (anti-CCP) antibodies

Matches

Show answer & explanation

Answer

Anti-Scl-70 pairs with Diffuse cutaneous systemic sclerosis; Anti-Jo-1 pairs with Polymyositis / Dermatomyositis; Anti-U1 RNP pairs with Mixed connective tissue disease; Anti-CCP pairs with Rheumatoid arthritis.
Each autoantibody has a distinct clinical association that aids in differentiating various rheumatologic diseases. Anti-Scl-70 is linked to diffuse systemic sclerosis. Anti-Jo-1 is tied to inflammatory myopathies (polymyositis/dermatomyositis). Anti-U1 RNP defines mixed connective tissue disease. Anti-CCP is a highly specific marker for rheumatoid arthritis.

Step-by-Step Solution

1
Analyze the first antibody, Anti-Scl-70.
It pairs with diffuse cutaneous systemic sclerosis.
Anti-Scl-70 (anti-topoisomerase I) is a classic marker for the diffuse variant of systemic sclerosis.
2
Analyze the second antibody, Anti-Jo-1.
It pairs with polymyositis / dermatomyositis.
Anti-Jo-1 is an anti-synthetase antibody strongly associated with inflammatory myopathies.
3
Analyze the third antibody, Anti-U1 RNP.
It pairs with mixed connective tissue disease.
The defining serologic feature of mixed connective tissue disease is the presence of high-titer anti-U1 RNP antibodies.
4
Analyze the fourth antibody, Anti-CCP.
It pairs with rheumatoid arthritis.
Anti-CCP antibodies have very high specificity for rheumatoid arthritis and often appear before clinical symptoms.

Key Concept

Specific autoantibody profiles in rheumatologic conditions
Question 558Question →

Match each autoantibody to its most characteristic associated rheumatologic condition or clinical feature.

Click a left item, then click its matching right item

Items

Anti-cyclic citrullinated peptide (anti-CCP) antibodies
Anti-double-stranded DNA (anti-dsDNA) antibodies
Anti-centromere antibodies
Anti-Scl-70 (anti-topoisomerase I) antibodies

Matches

Show answer & explanation

Answer

The correct matches are: Anti-CCP with Rheumatoid Arthritis; Anti-dsDNA with Systemic Lupus Erythematosus; Anti-centromere with Limited Cutaneous Systemic Sclerosis; and Anti-Scl-70 with Diffuse Cutaneous Systemic Sclerosis.
Autoantibodies serve as crucial diagnostic and prognostic markers in rheumatology. Anti-CCP is highly specific for Rheumatoid Arthritis. Anti-dsDNA is specific for SLE and tracks disease activity. Anti-centromere and anti-Scl-70 help differentiate between limited and diffuse cutaneous systemic sclerosis, respectively, with each carrying distinct clinical features and visceral risks.

Step-by-Step Solution

1
Identify the disease association for anti-CCP antibodies.
Matches with Rheumatoid Arthritis.
Anti-CCP is the most specific serological marker for RA.
2
Identify the disease association for anti-dsDNA antibodies.
Matches with Systemic Lupus Erythematosus.
Anti-dsDNA is specific to SLE and its titer correlates with disease flares and renal involvement.
3
Identify the disease association for anti-centromere antibodies.
Matches with Limited Cutaneous Systemic Sclerosis.
It is the defining serological feature of limited systemic sclerosis (CREST syndrome).
4
Identify the disease association for anti-Scl-70 antibodies.
Matches with Diffuse Cutaneous Systemic Sclerosis.
It distinguishes the diffuse form of systemic sclerosis from the limited form and predicts a higher risk of interstitial lung disease.

Key Concept

Clinical utility of specific autoantibodies in the diagnosis and prognostication of systemic autoimmune diseases.
Question 559Question →

Match the following clinical presentations of patients with advanced HIV infection to the most appropriate initial targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

An immunocompromised patient (CD4 count = 35 cells/mm335 \text{ cells/mm}^3) complains of seeing 'floating spots' and progressive blurring of vision. Retinal examination demonstrates dense, yellowish-white areas of necrosis accompanied by perivascular hemorrhages.
Following a week of worsening headaches and lethargy, a patient with poorly controlled HIV (CD4 count = 80 cells/mm380 \text{ cells/mm}^3) undergoes a lumbar puncture. The cerebrospinal fluid has a significantly elevated opening pressure and tests positive for a capsular polysaccharide antigen.
A patient with advanced HIV (CD4 count = 150 cells/mm3150 \text{ cells/mm}^3) describes a three-week history of worsening shortness of breath on exertion and a nonproductive cough. High-resolution chest computed tomography reveals diffuse, bilateral ground-glass opacities.
Emergency medical services bring in a patient with known HIV (CD4 count = 40 cells/mm340 \text{ cells/mm}^3) after witnessing a generalized tonic-clonic seizure. Subsequent magnetic resonance imaging of the brain highlights several ring-enhancing lesions located within the basal ganglia.

Matches

Show answer & explanation

Answer

The correct matches are: 1) CMV retinitis matched to Valganciclovir, 2) Cryptococcal meningoencephalitis matched to Liposomal amphotericin B and flucytosine, 3) Pneumocystis jirovecii pneumonia matched to Trimethoprim-sulfamethoxazole, and 4) Toxoplasma encephalitis matched to Sulfadiazine, pyrimethamine, and leucovorin.
Each clinical vignette describes classic pathognomonic findings for specific HIV-related opportunistic infections. CMV retinitis presents with retinal hemorrhages and exudates and is treated with valganciclovir. Cryptococcal meningitis presents with elevated intracranial pressure and positive capsular antigen, requiring induction therapy with liposomal amphotericin B and flucytosine. PJP presents with bilateral ground-glass opacities and is treated with high-dose TMP-SMX. Toxoplasma encephalitis presents with ring-enhancing lesions and seizures, necessitating treatment with sulfadiazine, pyrimethamine, and leucovorin (to prevent pyrimethamine-induced hematologic toxicity).

Step-by-Step Solution

1
Identify the underlying opportunistic infection based on the clinical vignette findings and the patient's CD4 cell count threshold.
Diagnoses identified are CMV retinitis, Cryptococcal meningoencephalitis, Pneumocystis jirovecii pneumonia (PJP), and Toxoplasma gondii encephalitis.
Accurate pathogen identification is required to select the precise targeted antimicrobial therapy.
2
Select the appropriate first-line antimicrobial regimen for each definitively identified pathogen.
Matched each opportunistic infection to its respective gold-standard pharmacotherapy.
Using the correct targeted therapy maximizes clinical efficacy and adheres to established infectious disease guidelines.

Key Concept

Diagnosis and first-line targeted therapy of major opportunistic infections in patients with advanced HIV based on CD4 count thresholds and classic clinical presentations.
Question 560Question →

Match each pediatric patient presenting for a routine well-child visit with the corresponding age-appropriate universal screening test recommended by the American Academy of Pediatrics.

Click a left item, then click its matching right item

Items

A 12-month-old asymptomatic boy with no significant medical or family history
An 18-month-old asymptomatic girl with typical development and growth
A 4-year-old asymptomatic boy preparing to start a preschool program
A 10-year-old asymptomatic girl with an active lifestyle
A 12-year-old asymptomatic boy attending the clinic for an annual physical examination

Matches

Show answer & explanation

Answer

The 12-month-old matches with hemoglobin measurement. The 18-month-old matches with the autism screening tool. The 4-year-old matches with objective visual acuity testing. The 10-year-old matches with a lipid profile. The 12-year-old matches with the standardized depression screening questionnaire.
The correct matches align with the American Academy of Pediatrics (AAP) periodicity schedule for universal screening. At 12 months, infants are universally screened for anemia. At 18 months, toddlers receive their first formal autism spectrum disorder screening. At 4 years, children are cognitively mature enough for objective visual acuity testing using a chart. Between ages 9 and 11 (e.g., 10 years old), children undergo universal dyslipidemia screening. At 12 years, universal depression screening begins for adolescents.

Step-by-Step Solution

1
Identify the purpose of the clinical encounter.
Each scenario describes a routine health maintenance examination for an asymptomatic pediatric patient at a specific age milestone.
This establishes that universal screening guidelines, rather than targeted risk-based guidelines, apply.
2
Recall the American Academy of Pediatrics (AAP) Bright Futures periodicity schedule.
Identify the specific universal screening tests uniquely introduced or emphasized at 12 months, 18 months, 4 years, 10 years, and 12 years.
Matching age milestones to screening protocols is a core competency in pediatric preventive care.
3
Pair each patient profile with the correct intervention.
12 months to anemia screening, 18 months to autism screening, 4 years to vision testing, 10 years to lipid screening, and 12 years to depression screening.
This completes the matching requirement based on established pediatric guidelines.

Key Concept

Universal Pediatric Screening Guidelines (AAP Bright Futures periodicity schedule)
PreviousPage 28 / 93Next
All practice questions — USMLE Step 2 CK | Examkin